Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Target Ovarian Cancer is the UK's leading ovarian cancer charity, dedicated to improving survival rates and providing comprehensive support for those affected by the disease. The organization focuses on three primary pillars: funding life-saving research, campaigning for early diagnosis, and providing expert support and information services. They work closely with the clinical community to improve standards of care and advocate for better access to treatments and genetic testing across the UK. Through their research program, they fund innovative projects aimed at understanding the biology of ovarian cancer and developing more effective, personalized therapeutic strategies. The charity also operates a nurse-led support line and provides resources for both patients and healthcare professionals to ensure no woman is left behind.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Target Ovarian Cancer.